A 6-Month Extension Study To The B2061032 Study To Evaluate The Safety, Tolerability, And Efficacy Of DVS SR In The Treatment Of Child And Adolescent Outpatients With MDD

Completed · Phase 3

Conditions studied: Major Depressive Disorder

In brief

This is a 6-month, open-label, flexible-dose study evaluating Desvenlafaxine Succinate Sustained-Release (DVS SR) in the Treatment of Child and Adolescent Outpatients with Major Depressive Disorder (MDD).

Key facts

Study ID

NCT01371708

Run by

Pfizer

People needed

283

Starts

2012-02-02

Expected to finish

2016-04-22

Last updated by the study team

2017-07-27

Who can join

Age: 7 and older, up to 17. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Completed study B2061032 and who in the investigator's opinion, would benefit from long term treatment with DVS SR
• Willingness and ability to comply with scheduled visits, treatment plan, and procedures

You may not qualify if…

• Requires precaution against suicide
• Not in generally healthy medical condition
• Poor compliance with study drug or study procedures during participation in study B2061032

Where it is running

• The University Of Alabama At Birmingham, Office Of Psychiatric Research — Birmingham, Alabama, United States
• Center for Advanced Improvement — Tucson, Arizona, United States
• Sun Valley Research Center — Imperial, California, United States
• MCB Clinical Research Centers — Colorado Springs, Colorado, United States
• Institute of Living/Hartford Hospital — Hartford, Connecticut, United States
• SJS Clinical Research, Inc. — Destin, Florida, United States
• Sarkis Clinical Trials — Gainesville, Florida, United States
• Clinical Neuroscience Solutions — Jacksonville, Florida, United States
• Medical Research Group of Central Florida — Orange City, Florida, United States
• Millenia Psychiatry & Research, Inc. — Orlando, Florida, United States
• Janus Center for Psychiatric Research — West Palm Beach, Florida, United States
• Northwest Behavioral Research Center — Marietta, Georgia, United States
• Capstone Clinical Research — Libertyville, Illinois, United States
• Baber Research Group — Naperville, Illinois, United States
• Clinco — Terre Haute, Indiana, United States
• Pharmasite Research, Inc — Baltimore, Maryland, United States
• Millennium Psychiatric Associates, LLC — Creve Coeur, Missouri, United States
• Premier Psychiatric Research Institute, LLC — Lincoln, Nebraska, United States
• Erie County Medical Center/State University of New York (SUNY) at Buffalo Affiliate — Buffalo, New York, United States
• The Zucker Hillside Hospital, North Shore-Long Island Jewish Health System — Glen Oaks, New York, United States
• Bioscience Research, LLC. — Mount Kisco, New York, United States
• Finger Lakes Clinical Research — Rochester, New York, United States
• Stony Brook University Medical Center, child and Adolescent Psychiatry — Stony Brook, New York, United States
• Neuro-Behavioral Clinical Research, Inc. — Canton, Ohio, United States
• Discovery and Wellness Center for Children/University Hospitals Case Medical Center — Cleveland, Ohio, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.